United States· US:16714-676_56193072-5059-54dc-e063-6294a90ac119

Sunitinib malate

A medicinal product containing sunitinib malate, registered in United States by NorthStar RxLLC.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSunitinib malateATC—REGISTER NO.US:16714-676_56193072…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SUNITINIB MALATE
Manufacturer
NorthStar RxLLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    16714-676-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sunitinib malate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sunitinib malate products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Finland · Sunitinib Avansor
  • Luxembourg · Sunitinib Synthon
  • Malta · Subinit
  • Netherlands · Sunitinib Malate Eugia, Sunitinib Synthon
  • Poland · Sunitinib, Sunitinib Synthon
  • Sweden · Sunitinib Avansor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6ab0a3d0-1fe1-4045-977b-19890768f49a
GET /v1/drugs/6ab0a3d0-1fe1-4045-977b-19890768f49a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "12.5",
  "substance": "SUNITINIB MALATE",
  "productndc": "16714-676",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA213914",
  "marketing_category": "ANDA"
}

See everything about sunitinib malate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.